Picture of Crestwood Equity Partners LP logo

CEQP — Crestwood Equity Partners LP News Story

0.000.00%
us flag iconLast trade - 00:00
EnergyBalancedMid Cap

U.S. RESEARCH ROUNDUP- Albemarle, Okta, Walgreens

April 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Albemarle, Okta and Walgreens on Monday. 
    
  HIGHLIGHTS        
     * Albemarle Corp  ALB.N : Citigroup raises price target to $262 from $244
     * Constellation Brands Inc  STZ.N : JP Morgan cuts target price to $276 from $278
     * Okta Inc  OKTA.O : BTIG cuts target price to $216 from $273
     * Travelers Companies Inc  TRV.N : RBC raises target price to $190 from $170
     * Walgreens  WBA.O : Baird cuts to neutral; cuts target price to $51 from $70
                
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.      
     * Albemarle Corp  ALB.N : Citigroup raises price target to $262 from $244
     * Ameriprise Financial Inc  AMP.N : Jefferies raises target price to $350 from $325
     * Apellis Pharmaceuticals Inc  APLS.O : JP Morgan raises target price to $69 from $66
     * Calithera Biosciences Inc  CALA.O : SVB Leerink cuts target price to $2 from $3
     * Constellation Brands Inc  STZ.N : JP Morgan cuts target price to $276 from $278
     * Core & Main Inc  CNM.N : Credit Suisse cuts target price to $35 from $40
     * Crestwood Equity Partners LP  CEQP.N : RBC raises target price to $38 from $35
     * Finch Therapeutics Group Inc  FNCH.O : Jefferies cuts target price to $17 from $29
     * Gilead Sciences Inc  GILD.O : Piper Sandler cuts target price to $71 from $77
     * Invitation Homes Inc  INVH.N : JP Morgan raises target price to $45 from $44
     * IRhythm Technologies Inc  IRTC.O : JP Morgan raises target price to $192 from $156
     * National Bank Holdings Corp  NBHC.N : Piper Sandler cuts target price to $49 from $52
     * nCino Inc  NCNO.O : Stephens cuts target price to $55 from $80
     * Neurocrine Biosciences Inc  NBIX.O : JP Morgan raises target price to $126 from $125
     * Okta Inc  OKTA.O : BTIG cuts target price to $216 from $273
     * Okta Inc  OKTA.O : Wells Fargo cuts target price to $175 from $235
     * Post Holdings Inc  POST.N : Piper Sandler cuts target price to $84 from $129
     * Replimune Group Inc  REPL.O : JP Morgan cuts target price to $39 from $47
     * Sunpower Corp  SPWR.O : JP Morgan raises target price to $21 from $20
     * Travelers Companies Inc  TRV.N : RBC raises target price to $190 from $170
     * Walgreens  WBA.O : Baird cuts to neutral; cuts target price to $51 from $70
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Crestwood Equity Partners LP

See all news